Allegro Ophthalmics to Present the Results of Its ALG-1007 Ex-U.S. Trial for Dry Eye Disease at the 2019 ASCRS•ASOA Annual Meeting

SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/ASCRS?src=hash" target="_blank"gt;#ASCRSlt;/agt;--Allegro Ophthalmics announced that the results of its ALG-1007 ex-U.S. clinical trial for the treatment of dry eye disease will be presented at ASCRS.

Full Story →